MDM2-ALT2 has been described as associated with both pro-oncogenic and growth-inhibitory phenotypes and perinatal lethality; it may also be important in the development of highly undifferentiated, aggressive mammary tumors [12,17]. Here, GPT2 is linked to breast cancer.